Dormant Company Accounts - BISCAYNE PHARMACY LIMITED

Dormant Company Accounts - BISCAYNE PHARMACY LIMITED


Companies House true 2022-10-01 2023-09-30 false 07778666 uk-bus:Director1 2022-10-01 2023-09-30 07778666 uk-bus:Director2 2022-10-01 2023-09-30 07778666 2022-10-01 2023-09-30 07778666 2023-09-30 07778666 uk-bus:EntityHasNeverTraded 2022-10-01 2023-09-30 07778666 uk-bus:FRS102 2022-10-01 2023-09-30 07778666 uk-bus:FullAccounts 2022-10-01 2023-09-30 07778666 uk-bus:AuditExempt-NoAccountantsReport 2022-10-01 2023-09-30 07778666 2022-09-30 07778666 uk-bus:OrdinaryShareClass1 2022-10-01 2023-09-30 07778666 uk-bus:OrdinaryShareClass2 2022-10-01 2023-09-30 07778666 uk-bus:OrdinaryShareClass3 2022-10-01 2023-09-30 07778666 uk-bus:PreferenceShareClass1 2022-10-01 2023-09-30 07778666 uk-bus:PreferenceShareClass2 2022-10-01 2023-09-30 07778666 uk-bus:PreferenceShareClass3 2022-10-01 2023-09-30 07778666 uk-core:ShareCapitalPreferenceShares 2023-09-30 07778666 uk-core:ShareCapitalPreferenceShares 2022-09-30 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 07778666

BISCAYNE PHARMACY LIMITED

Dormant Accounts

30 September 2023

BISCAYNE PHARMACY LIMITED Registered Number 07778666

Balance Sheet as at 30 September 2023

2023 2022
£ £
Called up share capital not paid
100
100
Net assets
100
100
Issued share capital
100 Ordinary Shares of £ 1 each 100 100
Total Shareholder funds
100
100

STATEMENTS

  1. For the year ending 30 September 2023 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 30 September 2023

And signed on their behalf by:
KEVSHEIK PATEL, Director